COX-inhibirajući donor azot oksida (Serbian Wikipedia)
Analysis of information sources in references of the Wikipedia article "COX-inhibirajući donor azot oksida" in Serbian language version.
refsWebsite
Global rank
Serbian rank
6th place
5th place
14th place
22nd place
3,395th place
3,163rd place
low place
low place
1st place
1st place
archive.org
- Wallace JL, Reuter BK, Cicala C, McKnight W, Grisham MB, Cirino G (1994). „Novel nonsteroidal anti-inflammatory drug derivatives with markedly reduced ulcerogenic properties in the rat”. Gastroenterology. 107 (1): 172—179. PMID 8020659. doi:10.1016/0016-5085(94)90074-4.
- Wallace JL, Cirino G (1994). „The development of gastrointestinal-sparing anti-inflammatory drugs”. Trends Pharmacol Sci. 15 (11): 405—406. PMID 7855901. doi:10.1016/0165-6147(94)90083-3.
- Keeble JE, Moore PK (2002). „Pharmacology and potential therapeutic applications of nitric oxide-releasing non-steroidal anti-inflammatory and related nitric oxide-donating drugs”. Br J Pharmacol. 137 (3): 295—310. PMC 1573498
. PMID 12237248. doi:10.1038/sj.bjp.0704876. - White, WB (2007). „Cardiovascular effects of the cyclooxygenase inhibitors”. Hypertension. 49 (3): 408—418. PMID 17261646. doi:10.1161/01.HYP.0000258106.74139.25 .
archive.today
- „John Wallace, Professor, Department of Pharmacology and Therapeutics, University of Calgary”. Архивирано из оригинала 2012-09-13. г. Приступљено 2017-08-25.
doi.org
- Wallace JL, Reuter BK, Cicala C, McKnight W, Grisham MB, Cirino G (1994). „Novel nonsteroidal anti-inflammatory drug derivatives with markedly reduced ulcerogenic properties in the rat”. Gastroenterology. 107 (1): 172—179. PMID 8020659. doi:10.1016/0016-5085(94)90074-4.
- Wallace JL, Cirino G (1994). „The development of gastrointestinal-sparing anti-inflammatory drugs”. Trends Pharmacol Sci. 15 (11): 405—406. PMID 7855901. doi:10.1016/0165-6147(94)90083-3.
- Keeble JE, Moore PK (2002). „Pharmacology and potential therapeutic applications of nitric oxide-releasing non-steroidal anti-inflammatory and related nitric oxide-donating drugs”. Br J Pharmacol. 137 (3): 295—310. PMC 1573498 . PMID 12237248. doi:10.1038/sj.bjp.0704876.
- White, WB (2007). „Cardiovascular effects of the cyclooxygenase inhibitors”. Hypertension. 49 (3): 408—418. PMID 17261646. doi:10.1161/01.HYP.0000258106.74139.25 .
drugdevelopment-technology.com
nicox.com
- „NicOx pipeline: product portfolio”. Архивирано из оригинала 2007-12-14. г. Приступљено 2007-12-27.
nih.gov
ncbi.nlm.nih.gov
- Wallace JL, Reuter BK, Cicala C, McKnight W, Grisham MB, Cirino G (1994). „Novel nonsteroidal anti-inflammatory drug derivatives with markedly reduced ulcerogenic properties in the rat”. Gastroenterology. 107 (1): 172—179. PMID 8020659. doi:10.1016/0016-5085(94)90074-4.
- Wallace JL, Cirino G (1994). „The development of gastrointestinal-sparing anti-inflammatory drugs”. Trends Pharmacol Sci. 15 (11): 405—406. PMID 7855901. doi:10.1016/0165-6147(94)90083-3.
- Keeble JE, Moore PK (2002). „Pharmacology and potential therapeutic applications of nitric oxide-releasing non-steroidal anti-inflammatory and related nitric oxide-donating drugs”. Br J Pharmacol. 137 (3): 295—310. PMC 1573498 . PMID 12237248. doi:10.1038/sj.bjp.0704876.
- White, WB (2007). „Cardiovascular effects of the cyclooxygenase inhibitors”. Hypertension. 49 (3): 408—418. PMID 17261646. doi:10.1161/01.HYP.0000258106.74139.25 .
ucalgary.ca
- „John Wallace, Professor, Department of Pharmacology and Therapeutics, University of Calgary”. Архивирано из оригинала 2012-09-13. г. Приступљено 2017-08-25.
web.archive.org
- „NicOx pipeline: product portfolio”. Архивирано из оригинала 2007-12-14. г. Приступљено 2007-12-27.